NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a licensing agreement with Merck & Co., Inc. NextBio offers the life sciences enterprise secure data access, knowledge discovery and collaboration tools, and enterprise integration capabilities for seamless correlation of internal research data.
“We are pleased Merck has chosen NextBio as a drug discovery and development partner,” said Saeid Akhtari, Co-Founder and Chief Executive Officer of NextBio. “Merck’s adoption of the NextBio solution validates our unique approach to solving the information bottleneck currently impacting research-driven pharmaceutical and biotechnology companies worldwide. We look forward to further building and extending our relationship with Merck’s researchers over the coming years.”
About NextBio
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio’s platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. NextBio helps organizations increase productivity and dramatically improve collaboration across therapeutic groups and geographic boundaries. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
Today, NextBio is used by over a million researchers at the world’s top commercial and academic institutions. NextBio’s enterprise solution has been deployed at Burnham Institute for Medical Research, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Regeneron, Scripps Research Institute, Stanford University, and Takeda, among many others. To learn more about NextBio, please visit our website at www.nextbio.com : .
NextBioAndrew Grygiel, 408-861-3602Vice President, Marketing andrew@nextbio.com : orKureczka/Martin AssociatesJoan Kureczka, 415-821-2413 Jkureczka@comcast.net : mailto:Jkureczka@comcast.net
